Literature DB >> 12658782

Analysis on the causes for refractory GERD.

Jie Chen1, Junying Xu, Yong Xu, Xiaoping Xie, Cuiqiong Yi, Xiaohua Hou.   

Abstract

To analyze the causes of failure in conventional treatment to refractory gastroesophageal reflux diseases (GERD) patients, 16 refractory GERD patients (group R) and 16 cases of GERD primarily diagnosed (group P) were studied. Endoscopy, pathologic examination and 14C urea breath test were conducted in every patient. 24 h ambulatory pH and bilirubin monitoring were performed with Digitrapper MK III and Synetics Bilitec 2000. It was found that esophagitis in group R was more severe than in group P. The rate of Helicobacter pylori infection in group R was significantly lower than in group P. Fraction time pH below 4.00 was not longer while the bile reflux represented by fraction time abs above 0.14 was greater for patients in the group R as compared with those in the group P. The mixed refluxes and pure bile refluxes between the two groups had significant difference. The reflux episodes in the group R mainly occurred during nights. These results indicated that severe esophagitis, especially Barrett's esophagus with complications makes it difficult to control GERD. Severe duodenogastroesophageal refluxes (DGER) are often accompanied by refractory GERD. Mixed refluxes aggravate the esophageal injuries. Pure bile refluxes and nocturnal refluxes may cause failure of administration of proton pump inhibitors (PPI) in the morning. Helicobacter pylori infection and acid refluxes may not be the direct cause of refractoriness. Individual refractory GERD patient without abnormal results on pH or bile reflux recently should be diagnosed again.

Entities:  

Mesh:

Year:  2002        PMID: 12658782     DOI: 10.1007/BF02904787

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  4 in total

1.  Dietary interference with the use of Bilitec to assess bile reflux.

Authors:  M W Barrett; J C Myers; D I Watson; G G Jamieson
Journal:  Dis Esophagus       Date:  1999       Impact factor: 3.429

2.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.

Authors:  D Nehra; P Howell; C P Williams; J K Pye; J Beynon
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 3.  Medical therapy. Management of the refractory patient.

Authors:  J G Hatlebakk; P O Katz; D O Castell
Journal:  Gastroenterol Clin North Am       Date:  1999-12       Impact factor: 3.806

4.  Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.

Authors:  P O Katz; C Anderson; R Khoury; D O Castell
Journal:  Aliment Pharmacol Ther       Date:  1998-12       Impact factor: 8.171

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.